Division of Gastroenterology and Hepatology

Medicine & Life Sciences

1. Helicobacter pylori 100%
2. Colorectal Neoplasms 94%
3. Taiwan 79%
4. Hepatocellular Carcinoma 70%
5. Stomach 65%
6. Neoplasms 65%
7. Stomach Neoplasms 47%
8. Apoptosis 42%
9. Carcinoma 37%
10. Liver Cirrhosis 36%
11. Therapeutics 34%
12. Proteins 30%
13. Helicobacter Infections 29%
14. Duodenal Ulcer 29%
15. Colonic Neoplasms 28%
16. 15,16-dihydrotanshinone I 27%
17. Endoscopic Mucosal Resection 26%
18. Intussusception 26%
19. Colonoscopy 26%
20. Non-alcoholic Fatty Liver Disease 25%
21. Liver 23%
22. Drug Therapy 23%
23. Ulcer 23%
24. Adenocarcinoma 22%
25. Raman Spectrum Analysis 22%
26. Catenins 21%
27. cytolethal distending toxin 21%
28. Serum 21%
29. Recurrence 20%
30. Pylorus 20%
31. Metaplasia 20%
32. Cellular Apoptosis Susceptibility Protein 20%
33. Survival 19%
34. Neoplastic Stem Cells 19%
35. Mucous Membrane 19%
36. glucose-regulated proteins 18%
37. Neoplasm Metastasis 18%
38. Peptic Ulcer 18%
39. lipoteichoic acid 18%
40. Heme Oxygenase-1 17%
41. Confidence Intervals 17%
42. Odds Ratio 17%
43. Lipopolysaccharides 16%
44. Fatty Liver 16%
45. Gastrointestinal Diseases 16%
46. Population 16%
47. Chromosome Segregation 16%
48. Fluorouracil 16%
49. Phosphotransferases 16%
50. Chronic Hepatitis C 16%
51. Chronic Hepatitis B 16%
52. Cetuximab 16%
53. Digestive System Endoscopy 16%
54. Pancreatic Neoplasms 15%
55. Radiofrequency Ablation 15%
56. Prostatic Neoplasms 15%
57. Hepacivirus 15%
58. Esomeprazole 15%
59. Nitric Oxide 15%
60. Growth 15%
61. Solanum nigrum 15%
62. Esophagitis 15%
63. Inflammation 15%
64. Endoscopy 15%
65. Cell Proliferation 14%
66. Cisplatin 14%
67. Stomach Ulcer 14%
68. evodiamine 14%
69. osthol 14%
70. Pancreatitis 14%
71. Extracellular Signal-Regulated MAP Kinases 14%
72. fisetin 13%
73. ErbB Receptors 13%
74. rhodamine 6G 13%
75. cobaltiprotoporphyrin 13%
76. Cholesterol 13%
77. Gastritis 13%
78. Biomarkers 13%
79. Randomized Controlled Trials 13%
80. Gold 13%
81. Proton Pump Inhibitors 13%
82. Liver Neoplasms 13%
83. Cell Line 13%
84. Gastrointestinal Endoscopy 13%
85. Epithelial Cells 12%
86. Messenger RNA 12%
87. Meta-Analysis 12%
88. Multicenter Studies 12%
89. zinc protoporphyrin 12%
90. Alanine Transaminase 12%
91. Reactive Oxygen Species 12%
92. Heterografts 12%
93. Systematic Reviews 12%
94. JNK Mitogen-Activated Protein Kinases 12%
95. Phosphorylation 12%
96. Mutation 12%
97. Iron 12%
98. Nanoparticles 12%
99. Campylobacter jejuni 11%
100. Mortality 11%